Next Article in Journal
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells
Next Article in Special Issue
miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer
Previous Article in Journal
18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
Previous Article in Special Issue
WWC Proteins: Important Regulators of Hippo Signaling in Cancer
 
 
Review

Article Versions Notes

Cancers 2021, 13(2), 318; https://doi.org/10.3390/cancers13020318
Action Date Notes Link
article xml file uploaded 16 January 2021 10:34 CET Original file -
article xml uploaded. 16 January 2021 10:34 CET Update https://www.mdpi.com/2072-6694/13/2/318/xml
article pdf uploaded. 16 January 2021 10:34 CET Version of Record https://www.mdpi.com/2072-6694/13/2/318/pdf
article html file updated 16 January 2021 10:35 CET Original file -
article html file updated 23 July 2022 17:45 CEST Update https://www.mdpi.com/2072-6694/13/2/318/html
Back to TopTop